Acotec Scientific Holdings Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Acotec Scientific Holdings has a total shareholder equity of CN¥1.3B and total debt of CN¥55.0M, which brings its debt-to-equity ratio to 4.1%. Its total assets and total liabilities are CN¥1.7B and CN¥371.9M respectively. Acotec Scientific Holdings's EBIT is CN¥17.7M making its interest coverage ratio -1.2. It has cash and short-term investments of CN¥927.2M.
Wichtige Informationen
4.1%
Verhältnis von Schulden zu Eigenkapital
CN¥54.97m
Verschuldung
| Zinsdeckungsgrad | -1.2x |
| Bargeld | CN¥927.21m |
| Eigenkapital | CN¥1.34b |
| Gesamtverbindlichkeiten | CN¥371.93m |
| Gesamtvermögen | CN¥1.71b |
Jüngste Berichte zur Finanzlage
Recent updates
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 46% Undervalued
Mar 21
We Think Acotec Scientific Holdings (HKG:6669) Can Easily Afford To Drive Business Growth
Nov 17Acotec Scientific Holdings Limited's (HKG:6669) Intrinsic Value Is Potentially 42% Above Its Share Price
Oct 20Acotec Scientific Holdings (HKG:6669) Has More To Do To Multiply In Value Going Forward
Sep 24An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued
Jul 01Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 6669's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥190.7M).
Langfristige Verbindlichkeiten: 6669's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥181.2M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 6669 has more cash than its total debt.
Schulden abbauen: Insufficient data to determine if 6669's debt to equity ratio has reduced over the past 5 years.
Schuldendeckung: 6669's debt is well covered by operating cash flow (49.7%).
Zinsdeckung: 6669 earns more interest than it pays, so coverage of interest payments is not a concern.